Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2.
Liekniņa I. et al, (2024), NPJ Parkinson's disease, 10
Thioflavin T─a Reporter of Microviscosity in Protein Aggregation Process: The Study Case of α-Synuclein.
Rusakov K. et al, (2024), The journal of physical chemistry letters, 6685 - 6690
Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites
MacLean AJ. et al, (2022), Immunity
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Poggiolini I. et al, (2021), Brain
Dissection-independent production of Plasmodium sporozoites from whole mosquitoes
Blight J. et al, (2021), Life Science Alliance, 4, e202101094 - e202101094
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Voysey M. et al, (2021), The Lancet, 397, 881 - 891
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
Mohsen MO. et al, (2019), Journal for ImmunoTherapy of Cancer, 7
Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
C. Gomes A. et al, (2019), Vaccines, 7, 47 - 47
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
Mohsen MO. et al, (2019), Frontiers in Immunology, 10
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis
von Loga IS. et al, (2019), Annals of the Rheumatic Diseases, 78, 672 - 675
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
Mohsen MO. et al, (2019), Journal for immunotherapy of cancer, 7
The Prospects of an Active Vaccine Against Asthma Targeting IL-5
Bachmann MF. et al, (2018), Frontiers in Microbiology, 9
Active and Passive Immunization Against Type 2 Diabetes Mellitus
Roesti E. et al, (2018), SWISS MEDICAL WEEKLY, 148, 35S - 36S
Mutated as well as germ-line epitopes contribute to preclinical efficacy of virus-like particles based cancer vaccines
Mohsen MO. et al, (2018), SWISS MEDICAL WEEKLY, 148, 34S - 34S
Vaccination against nerve growth factor is an effective pain treatment in murine osteoarthritis
von Loga IS. et al, (2018), Osteoarthritis and Cartilage, 26, S355 - S355
Noninfectious Disease Vaccines
El-Turabi A. and Bachmann MF., (2018), Plotkin's Vaccines, 689 - 697.e4
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
Zeltins A. et al, (2017), npj Vaccines, 2
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Doucet M. et al, (2017), PLOS ONE, 12, e0181844 - e0181844
Microcrystalline Tyrosine (MCT): a depot adjuvant used in allergy offers new opportunities in infectious disease
Cabral-Miranda G. et al, (2017), ALLERGY, 72, 201 - 201